The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies?

By afschroeder • February 13, 2026

Barrett LG, Gangi A, Hendifar A, Osipov A, Atkins K, Zaghiyan K, Nasseri Y, Murrell Z, Waters K, Mehta P, Zell JA, Hitchins MP, Gong J. The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies? Transl Gastroenterol Hepatol. 2026 Jan 23;11:2. doi: 10.21037/tgh-25-75. PMID: 41675310; PMCID: PMC12887280.

Tags: adjuvant chemotherapy (ACT), Cedars Sinai DoM, circulating tumor DNA (ctDNA), Colon cancer, Hematology/Oncology, minimal residual disease (MRD), Publications

Timing of Hypertensive Disorders of Pregnancy in Nulliparous Individuals and Risk of Incident Chronic Hypertension 2-7 Years Postpartum

Hauspurg A, Grobman W, Jancsura MK, Yee LM, Waks A, Simhan H, Levine LD, Theilen L, Greenland P, McNeil R, Bairey Merz CN, Shahrokni N,[...]

Response

Geft D, Matusov Y, Kolaitis N, DesJardin J, Barnett C, Hage A, De Marco T, Lewis MI. Response. Chest. 2026 Feb;169(2):e80-e81. doi: 10.1016/j.chest.2025.11.028. PMID: 41672669.

Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis

Lewis S, Wildman-Tobriner B, Cuevas J, Calle S, Bolger I, Wang K, Joshi H, Mankowski Gettle L, Yang JD, Min JH, Sirlin CB, Reeder SB,[...]